BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17224008)

  • 21. A prospective comparison of four techniques for diagnosis of paroxysmal nocturnal hemoglobinuria.
    Gupta R; Pandey P; Choudhry R; Kashyap R; Mehrotra M; Naseem S; Nityanand S
    Int J Lab Hematol; 2007 Apr; 29(2):119-26. PubMed ID: 17474884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of unsuspected PNH-type cells in flow cytometric immunophenotypic analysis of peripheral blood and bone marrow.
    Thomason RW; Papiez J; Lee RV; Szczarkowski W
    Am J Clin Pathol; 2004 Jul; 122(1):128-34. PubMed ID: 15272541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased expression of complement regulatory proteins, CD55 and CD59, on peripheral blood leucocytes in patients with type 2 diabetes and macrovascular diseases.
    Ma XW; Chang ZW; Qin MZ; Sun Y; Huang HL; He Y
    Chin Med J (Engl); 2009 Sep; 122(18):2123-8. PubMed ID: 19781296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mean fluorescence intensity rate is a useful marker in the detection of paroxysmal nocturnal hemoglobinuria clones.
    Hevessy Z; Nagy B; Kiss F; Kiss A; Kappelmayer J
    Clin Chem Lab Med; 2005; 43(9):919-23. PubMed ID: 16176170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus (SLE) patients.
    Alegretti AP; Mucenic T; Merzoni J; Faulhaber GA; Silla LM; Xavier RM
    Cell Immunol; 2010; 265(2):127-32. PubMed ID: 20727519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL).
    Epling-Burnette PK; Bai F; Wei S; Chaurasia P; Painter JS; Olashaw N; Hamilton A; Sebti S; Djeu JY; Loughran TP
    Oncogene; 2004 Dec; 23(57):9220-9. PubMed ID: 15516985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of paroxysmal nocturnal hemoglobinuria-phenotype in patients with chronic lymphocytic leukemia and multiple myeloma.
    Varma S; Varma N; Reddy VV; Naseem S; Bose P; Malhotra P
    Indian J Pathol Microbiol; 2012; 55(2):206-10. PubMed ID: 22771645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Placental expression of glycophosphatidylinositol (GPI)-anchored proteins in paroxysmal nocturnal haemoglobinuria.
    Kristoffersen EK; Haram KO; Edvardsen B; Ernst P; Bjørge L
    Scand J Immunol; 2006 Aug; 64(2):140-4. PubMed ID: 16867159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD55 and CD59 deficiency in transplant patient populations: possible association with paroxysmal nocturnal hemoglobinuria-like symptoms in Campath-treated patients.
    Ruiz P; Weppler D; Tryphonopoulos P; Nishida S; Moon J; Kato T; Selvaggi G; Levi D; Madariaga J; DelaGarza J; Tuteja S; Garcia M; Tzakis A
    Transplant Proc; 2006; 38(6):1750-2. PubMed ID: 16908271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cell type lymphoproliferative disease of granular lymphocytes (LDGL) is equipped with a phenotypic pattern typical of effector cytotoxic cells.
    Baesso I; Pavan L; Boscaro E; Miorin M; Facco M; Trentin L; Agostini C; Zambello R; Semenzato G
    Leuk Res; 2007 Mar; 31(3):371-7. PubMed ID: 16982092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia.
    García-Valladares I; Atisha-Fregoso Y; Richaud-Patin Y; Jakez-Ocampo J; Soto-Vega E; Elías-López D; Carrillo-Maravilla E; Cabiedes J; Ruiz-Argüelles A; Llorente L
    Lupus; 2006; 15(9):600-5. PubMed ID: 17080916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variant lymphoproliferative disorder of granular lymphocytes (LDGL) following Hodgkin lymphoma.
    Jenkins BD; Snower D; Mohamed A; Al-Katib A
    Am J Hematol; 2005 Jun; 79(2):128-31. PubMed ID: 15929104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of CD55- and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes.
    Meletis J; Terpos E; Samarkos M; Meletis C; Apostolidou E; Komninaka V; Korovesis K; Mavrogianni D; Boutsis D; Variami E; Viniou N; Konstantopoulos K; Loukopoulos D
    Hematol J; 2001; 2(1):33-7. PubMed ID: 11920231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of complement regulatory proteins on human natural killer cell subsets.
    Wang L; Halliday D; Johnson PM; Christmas SE
    Immunol Lett; 2007 Oct; 112(2):104-9. PubMed ID: 17719652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Aggressive natural killer cell lymphoproliferative disease of large granular lymphocytes with leukemia-like clinical course in the terminalstage].
    Tsukada T; Ohno T; Morita K; Otsuji H; Sekine T; Nishikawa M; Kobayashi T; Kita K; Shirakawa S; Namba K
    Rinsho Ketsueki; 1991 Feb; 32(2):162-6. PubMed ID: 2027242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis of paroxysmal nocturnal hemoglobinuria with cytofluorometric of molecules bound to the membrane by glycosylphosphatidylinositol groups].
    Villamor N; Marín P; Aymerich M; Arriols R; Rovira M; Bosch F; Vilella R; Rozman C; Vives-Corrons JL
    Med Clin (Barc); 1994 Apr; 102(13):481-4. PubMed ID: 8208005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis.
    Semenzato G; Zambello R; Starkebaum G; Oshimi K; Loughran TP
    Blood; 1997 Jan; 89(1):256-60. PubMed ID: 8978299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of lymphoproliferative disorder of granular lymphocytes in association with hairy cell leukemia.
    Xie XY; Sorbara L; Kreitman RJ; Fukushima PI; Kingma DW; Stetler-Stevenson M
    Leuk Lymphoma; 2000 Mar; 37(1-2):97-104. PubMed ID: 10721773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic analysis of affected peripheral erythroid for CD59 in paroxysmal nocturnal hemoglobinuria.
    Cui W; Lin Q; Zhang Z
    Chin Med J (Engl); 2002 Feb; 115(2):206-8. PubMed ID: 11940332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural killer cells are deficient in the surface expression of the complement regulatory protein, decay accelerating factor (DAF).
    Nicholson-Weller A; Russian DA; Austen KF
    J Immunol; 1986 Aug; 137(4):1275-9. PubMed ID: 3090145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.